New Pills for Endometriosis: Options and Pain Relief

Advanced Endometriosis Treatment: Discover the New Pills

Reading time : 1 minute, Discovery Chepe Id-614-SAL
Published in 03-14-2025

Endometriosis is a chronic disease that affects millions of women worldwide, causing severe pelvic pain and fertility issues. The approval of a new pill represents a significant step forward in treating this condition, providing an effective alternative to traditional therapies.

Name and composition of the medication
The new drug, called Ryeqo, combines three active ingredients: relugolix, estradiol, and norethisterone acetate. These components work together to regulate hormone levels and reduce the growth of endometrial-like tissue outside the uterus, helping to alleviate pain and improve patients' quality of life.

Mechanism of action
Relugolix acts as a gonadotropin-releasing hormone (GnRH) inhibitor, suppressing estrogen production, while estradiol and norethisterone acetate help counteract some of the side effects associated with reduced hormone levels. Thanks to this combination, a hormonal balance is achieved that alleviates endometriosis symptoms.

Endometriosis: What Are the Latest Pills Available?

Approval and availability
The National Health Service (NHS) in England has recently approved Ryeqo for the treatment of endometriosis, marking a milestone in the availability of therapeutic options for this disease. Other countries are expected to follow suit and authorize its commercialization in the coming months.

Benefits for patients
Women who have tried the new pill report a significant reduction in menstrual pain and an overall improvement in their well-being. Additionally, since it is an oral treatment, it eliminates the need for injections or invasive surgeries, providing an advantage in terms of convenience and accessibility.

Possible side effects
Like any medication, Ryeqo may have side effects. Some of the most common include hot flashes, mood changes, and alterations in the menstrual cycle. However, most patients have tolerated the treatment well and have experienced significant improvements in their quality of life.

Future perspectives
The arrival of this new pill paves the way for future research in endometriosis treatment. With increasing awareness of this disease, advancements are expected to continue, providing women with more effective and less invasive therapeutic options.

Endometriosis has been an underestimated disease for years, but with the approval of new treatments like Ryeqo, patients now have renewed hope. This drug represents a major medical breakthrough and could transform the lives of many women worldwide.